- Home
- SRFM vs SCNX Comparison
SRFM vs SCNX Comparison
Compare SRFM & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRFM | SCNX |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.0M | 16.2M |
| IPO Year | 2023 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SRFM | SCNX |
|---|---|---|
| Price | $0.51 | $0.35 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $3.25 | $1.50 |
| AVG Volume (30 Days) | ★ 1.7M | 361.9K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.69 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $106,557,000.00 | $3,831,778.00 |
| Revenue This Year | $25.90 | $1,097.38 |
| Revenue Next Year | $20.72 | $239.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 30.72 |
| 52 Week Low | $0.50 | $0.24 |
| 52 Week High | $6.17 | $2.60 |
Technical Indicators
Market Signals| Indicator | SRFM | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 31.34 | 40.47 |
| Support Level | N/A | $0.30 |
| Resistance Level | $0.75 | $0.43 |
| Average True Range (ATR) | 0.04 | 0.03 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 5.18 | 17.56 |
Price Performance
Historical ComparisonAbout SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc is a regional air mobility platform operating commuter airlines in the United States and expanding an on-demand charter marketplace for passengers in the U.S. and globally. It is also focused on developing a proprietary aviation software, aircraft electrification powertrain technology and services to enable electrification across the regional air mobility sector. The company operates in a single reportable segment, Air Mobility. The Air Mobility segment derives revenue from operating scheduled commercial air service flights, which are sold to the public mainly on a per-seat basis; through subsidized EAS revenue awards from the Department of Transportation; and by operating on-demand flights for customers on an ad-hoc, by request basis.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.